These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12176412)

  • 1. Induction of prolonged survival of fully allogeneic cardiac graft by intratracheal delivery of a single major histocompatibility [correction of histocompatability] complex class I peptide.
    Akiyama Y; Shibutani S; Matsumoto K; Kitajima M; Aramaki O; Yokoyama T; Kan S; Ikeda Y; Shirasugi N; Niimi M
    Transplant Proc; 2002 Aug; 34(5):1396-7. PubMed ID: 12176412
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of specific unresponsiveness to murine cardiac allografts by intrathymic inoculation of MHC class I allopeptides.
    Chowdhury NC; Jin MX; Athan ES; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):237-8. PubMed ID: 7878983
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene transfer of immunosuppressive peptides B2702 and RDP1257 prolongs allograft survival: evidence suggesting a role for heme oxygenase-I.
    Magee JC; DeBruyne LA; Buelow R; Bromberg JS
    Transplant Proc; 1999; 31(1-2):1194. PubMed ID: 10083532
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M
    Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of fully allogeneic cardiac allografts induced by delivery of alloantigen via respiratory mucosa is abrogated by blockade of the B7 pathway.
    Shirasugi N; Matsumoto S; Hamano K; Esato K; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Takami H; Kodaira S; Niimi M
    Transplant Proc; 2000 Nov; 32(7):2034. PubMed ID: 11120053
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of alloimmunity with class I MHC peptides: mechanisms of action.
    Mhoyan A; Wu GD; Que X; Cramer DV; Shirwan H
    Transplant Proc; 1999; 31(1-2):1189-91. PubMed ID: 10083530
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance.
    Shirwan H; Mhoyan A; Leamer M; Wang C; Cramer DV
    Transplant Proc; 1997; 29(1-2):1134-5. PubMed ID: 9123235
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells.
    Akiyama Y; Shirasugi N; Aramaki O; Matsumoto K; Shimazu M; Kitajima M; Ikeda Y; Niimi M
    Hum Immunol; 2002 Oct; 63(10):888-92. PubMed ID: 12368041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of MHC class I or class II "knock out" mice to investigate the role of these antigens in allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Demetris AJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):475-6. PubMed ID: 7879067
    [No Abstract]   [Full Text] [Related]  

  • 11. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transplant tolerance by intrathymic inoculation of synthetic MHC class I allopeptides.
    Chowdhury NC; Murphy B; Sayegh MH; Hardy MA; Oluwole SF
    Transplant Proc; 1997; 29(1-2):1136. PubMed ID: 9123236
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal induction of tolerance to cardiac allografts.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1994 Feb; 26(1):207-8. PubMed ID: 8108945
    [No Abstract]   [Full Text] [Related]  

  • 14. Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo.
    Spriewald BM; Billing JS; Jenkins S; Wheeler P; Steger U; Bushell A; Hyde K; Morris PJ; Wood KJ
    Transplantation; 2003 Feb; 75(4):537-41. PubMed ID: 12605123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small, resting B cells induce prolonged survival of cardiac allografts mismatched for single minor, but not multiple minor, single major, or multiple major and minor histocompatibility antigens.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1997; 29(1-2):1171. PubMed ID: 9123259
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of CD30 in skin and heart allograft rejection in the mouse.
    Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
    Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
    Qian S; Sun H; Demetris AJ; Fu F; Starzl TE; Fung JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):362-3. PubMed ID: 8438336
    [No Abstract]   [Full Text] [Related]  

  • 18. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Onodera K; Schaub M; Korom S; Binder J; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):1016. PubMed ID: 9123176
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.